ライフサイエンスコーパス: sinus rhythm

1 with chronic AF compared with individuals in sinus rhythm.

2 larization (APD90) compared with patients in sinus rhythm.

3 observations explained termination of AF to sinus rhythm.

4 .6+/-6.3 months, 67% of the patients were in sinus rhythm.

5 taRay catheter and Ensite NavX system during sinus rhythm.

6 nine of 49 (80%) patients remained in stable sinus rhythm.

7 paroxysmal AF when compared with patients in sinus rhythm.

8 oxyproline content compared with patients in sinus rhythm.

9 ons with a comparable rate of restoration of sinus rhythm.

10 educed left ventricular ejection fraction in sinus rhythm.

11 tion (AF) is an effective therapy to restore sinus rhythm.

12 olume index at HFpEF diagnosis compared with sinus rhythm.

13 rial fibrillation with that in patients with sinus rhythm.

14 ithout abnormal bipolar voltage (<1.5 mV) in sinus rhythm.

15 ve radiation dose than that in patients with sinus rhythm.

16 ent atrial fibrillation (AF) and controls in sinus rhythm.

17 al fibrillation (AF) in patients with normal sinus rhythm.

18 tients with left-sided heart disease-TR with sinus rhythm.

19 in in patients with heart failure and normal sinus rhythm.

20 n atrial ECG morphology identical to regular sinus rhythm.

21 diagnosis), concurrent AF (+/-3 months), or sinus rhythm.

22 worse cognitive performance than subjects in sinus rhythm.

23 on admission were compared with patients in sinus rhythm.

24 r for patients with heart failure who are in sinus rhythm.

25 ged QRS duration or Brugada pattern while in sinus rhythm.

26 n atrial fibrillation compared with those in sinus rhythm.

27 to convert ventricular tachyarrhythmia into sinus rhythm.

28 uires multiple procedures to maintain stable sinus rhythm.

29 AF may be different from that which controls sinus rhythm.

30 developed AF, whereas 36 remained in normal sinus rhythm.

31 ith either persistent atrial fibrillation or sinus rhythm.

32 tricle were performed in all patients during sinus rhythm.

33 whether this MR improves with restoration of sinus rhythm.

34 animals and all of the G628S animals were in sinus rhythm.

35 terminated the arrhythmia with resumption of sinus rhythm.

36 atrial fibrillation after cardiac surgery to sinus rhythm.

37 by ECGI; ablation near these sites restored sinus rhythm.

38 of drug therapy alone to lead to maintained sinus rhythm.

39 In Group A, 15 of 19 patients (79%) were in sinus rhythm.

40 s with reduced ejection fractions who are in sinus rhythm.

41 with better prognosis, but only for those in sinus rhythm.

42 rt failure with reduced ejection fraction in sinus rhythm.

43 atio, 5.43; 95% CI, 3.24-9.12) compared with sinus rhythm.

44 1 hour post procedure for the maintenance of sinus rhythm.

45 scar accurately identify VT channels during sinus rhythm.

46 emaker implantation, whereas the rest are in sinus rhythm.

47 found in atrial appendages from patients in sinus rhythm.

48 ricular endocardial mapping was performed in sinus rhythm.

49 litude signals usually occurring late during sinus rhythm.

50 e further intervention to maintain long term sinus rhythm.

51 sired procedural end point of termination to sinus rhythm.

52 nt reduction of AF burden and maintenance of sinus rhythm.

53 et of specific treatments intended to modify sinus rhythm.

54 ed by electroanatomic voltage mapping during sinus rhythm.

55 l or chronic AF and from control subjects in sinus rhythm.

56 ac magnetic resonance images acquired during sinus rhythm.

57 to values observed among control subjects in sinus rhythm.

58 at ICU discharge, 54 patients (75%) were in sinus rhythm.

59 equency than chloroquine and did not restore sinus rhythm (0/5).

60 This radiation dose reduction was seen with sinus rhythm (1.5 versus 16.7 mSv; P<0.0001) but was mor

61 patients with AF compared with patients with sinus rhythm: 10.6+/-5.5 versus 4.7+/-3.5 g, P<0.001.

62 re pericardial fat compared with patients in sinus rhythm (101.6 +/- 44.1 ml vs. 76.1 +/- 36.3 ml, p

63 d tomography in 273 patients: 76 patients in sinus rhythm, 126 patients with paroxysmal AF, and 71 pa

64 the number of shocks required to convert to sinus rhythm (2.25+/-1.24 versus 2.41+/-1.22, P=0.31).

65 AF who underwent catheter ablation while in sinus rhythm; 20 patients were induced into AF, 20 patie

66 f continuous AF: 2 in patients presenting in sinus rhythm, 3 in AF lasting 1 to 3 months, 4 in AF las

67 Fractionation during sinus rhythm (5.9+/-1.8 deflections; 9.2+/-4.4-ms interv

68 r in patients who developed AF versus normal sinus rhythm (6.13 +/- 2.9% vs. 2.03 +/- 1.9%, p = 0.03)

69 itral regurgitation due to flail leaflets in sinus rhythm (65+/-13 years; median EF, 66% [60%-71%]) e

70 6.3+/-0.7 Hz (P<0.005) just before restoring sinus rhythm (7/7).

71 ion to persistent AF and without reversal to sinus rhythm; 7 sheep were euthanized after 341.3+/-16.7

72 At 1-year follow-up, 70% remained in sinus rhythm (85% out-of-antiarrhythmic drugs).

73 14 ms, P = 0.04), of AH interval during both sinus rhythm (92 +/- 13 versus 76.8 +/- 8 ms, P < 0.01)

74 d significantly between patients with AF and sinus rhythm (AAbeta1AR=94% vs. 38%, p<0.001; AAM2R=88%

75 according to AF duration: PsAF presenting in sinus rhythm (AF induced), PsAF <12 months, and PsAF >12

76 dation set AF terminated in 57%, 61% were in sinus rhythm after 4.6 years.

77 in 81% during catheter ablation, 77% were in sinus rhythm after 6 years and multiple ablations.

78 tent AF, LA voltage maps were created during sinus rhythm after circumferential pulmonary vein isolat

79 In patients with persistent AF, PVAI in sinus rhythm after direct current cardioversion is assoc

80 F: pulmonary vein antral isolation (PVAI) in sinus rhythm after direct current cardioversion versus P

81 Another 14 (9.3%) patients maintained sinus rhythm after reinitiation of antiarrhythmic drugs,

82 in sinus rhythm, only 18 (33%) converted to sinus rhythm after repeated cardioversions, whereas the

83 mpared with left-sided heart disease-TR with sinus rhythm (all P<0.05).

84 diomyopathy (NYHA functional class II only), sinus rhythm, an ejection fraction of 30% or less, and p

85 was <10 g, and if the change was >/=4.5 g in sinus rhythm and >/=8 g in atrial fibrillation (P<0.0005

86 ) were 16% (2237 of 13,945) in patients with sinus rhythm and 21% (633 of 3064) in patients with atri

87 sessed and compared between 69 patients with sinus rhythm and 25 patients with atrial fibrillation.

88 were assessed, and of these 13,946 (76%) had sinus rhythm and 3066 (17%) had atrial fibrillation at b

89 ion, 914 radiofrequency applications (530 in sinus rhythm and 384 in atrial fibrillation) were analyz

90 We recruited 258 patients (209 patients in sinus rhythm and 49 with permanent atrial fibrillation)

91 rkshire swine were randomized into 2 groups (sinus rhythm and AF), and each group into 3 subgroups: s

92 ced ventricular rate by 12 beats/min in both sinus rhythm and AF.

93 4 (1.3, 1.9) mSv, with no difference between sinus rhythm and atrial fibrillation (1.4 versus 1.5 mSv

94 CF and CF parameters were similar during sinus rhythm and atrial fibrillation.

95 e integral between applications delivered in sinus rhythm and atrial fibrillation.

96 It has been studied for maintenance of sinus rhythm and control of ventricular response during

97 y maneuvering the minibasket catheter during sinus rhythm and coronary sinus pacing.

98 ctivity (VNA) and IVC-IAGPNA during baseline sinus rhythm and during pacing-induced sustained AF in 6

99 Activation maps were constructed during sinus rhythm and during VT.

100 l unipolar electrograms were recorded during sinus rhythm and ectopic activation, together with pseud

101 o simulate electrical activity during normal sinus rhythm and ectopic pacing.

102 Cholinergic stimulation not only can slow sinus rhythm and facilitate AF/AFL but also protects the

103 a from AF patients compared with patients in sinus rhythm and from mice infused with angiotensin II c

104 All were in sinus rhythm and had no history of atrial fibrillation,

105 tion from body surface potential maps during sinus rhythm and localizing endocardial and epicardial s

106 During sinus rhythm and long AV delays (>/=300 ms), 2 positive

107 Among 4,021 obese individuals with sinus rhythm and no history of atrial fibrillation, 2,00

108 ured in human atrial tissue from patients in sinus rhythm and permanent atrial fibrillation.

109 ry vein triggers improves the maintenance of sinus rhythm and reverses disease progression.

110 ed in human atrial myocytes from patients in sinus rhythm and that its expression was significantly g

111 followed >/=1 year to assess maintenance of sinus rhythm and to monitor changes in blood pressure.

112 resence of conduction disorders in BB during sinus rhythm and to study their relation with AF.

113 surface potential maps were recorded during sinus rhythm and ventricular stimulation from 27 endocar

114 atrial appendages obtained from patients in sinus rhythm and with chronic atrial fibrillation (CAF)

115 eats/min) following >/=120 minutes of stable sinus rhythm, and 22 were age- and sex-matched patients

116 ythm data, 382 (17%) had AF, 1,602 (70%) had sinus rhythm, and 308 (13%) had "other" rhythm.

117 underlying tachycardia mechanism to restore sinus rhythm, and atrioventricular junction ablation wit

118 anesthetized closed-chest pigs (n=5) during sinus rhythm, and epicardial and endocardial ventricular

119 40%, New York Heart Association class II-IV, sinus rhythm, and heart rate >/=70 beats per minute) and

120 Among patients with systolic heart failure, sinus rhythm, and heart rate >/=70 beats/min on recommen

121 ls, vernakalant-resistant AF was reverted to sinus rhythm, and reinduction of AF by burst pacing (50

122 ecutive patients with metabolic syndrome, in sinus rhythm, and undergoing coronary artery bypass graf

123 Sinus rhythm animals had strong transgene expression but

124 During sinus rhythm, APD was shorter in LWHs compared to LANG h

125 For a total of 255 patients in sinus rhythm, apical 4- and 2-chamber views were collect

126 was discontinued, and she reverted to normal sinus rhythm approximately 2 hr later.

127 in the latest isochrone of activation during sinus rhythm are infrequently correlated with successful

128 significantly more group B patients were in sinus rhythm as compared with patients in group A (30 [5

129 The primary outcome was return to sinus rhythm at 1 min after intervention, determined by

130 Her echocardiography demonstrated normal sinus rhythm at 73 beats per minute.

131 s, left atrium volume >165 mL, absent normal sinus rhythm at admission for EAM, and inducibility of a

132 tial structural heart disease, and in normal sinus rhythm at baseline were recruited from November 20

133 Of HFpEF patients in sinus rhythm at diagnosis, 32% developed AF over a media

134 Main exclusion criteria were absence of sinus rhythm at enrollment, cardiac transplantation, and

135 s were regular use of fish oil or absence of sinus rhythm at enrollment.

136 Efficacy in maintaining sinus rhythm at follow-up end was 60% (54%-67%).

137 mbined model of ECG and clinical parameters, sinus rhythm at long-term follow-up could be predicted w

138 redicted termination with an AUC of 0.70 and sinus rhythm at long-term follow-up with an AUC of 0.61.

139 AF history (no history of AF, AF history in sinus rhythm at surgery, and AF history in AF at surgery

140 Only 76% of patients were in normal sinus rhythm at the beginning of EAM.

141 terone Antagonist (TOPCAT) trial who were in sinus rhythm at the time of echocardiography.

142 llation episodes alternating with periods of sinus rhythm at the time of implantation had a better su

143 se pathways explains why, even during normal sinus rhythm, atrial breakthroughs could arise from a re

144 At normal sinus rhythm, AZD1305 increased QT and RR intervals from

145 Most patients return to sinus rhythm before discharge.

146 ctive than amiodarone for the maintenance of sinus rhythm, but has fewer adverse effects.

147 ssociated with atrial activation compared to sinus rhythm, but has limitations in providing specific

148 d death among patients with heart failure in sinus rhythm, but raises the risk of major bleeding; and

149 discharge, the majority of patients were in sinus rhythm, but the efficacy of repetitive electrical

150 o the procedural end point of termination to sinus rhythm by elimination of subsequent ATs (P=0.004).

151 on were compared with those in patients with sinus rhythm by using the weighted mean difference metho

152 gned to standard Valsalva manoeuvre achieved sinus rhythm compared with 93 (43%) of 214 in the modifi

153 blockers in patients with heart failure and sinus rhythm compared with atrial fibrillation.

154 apping points (1409 atrial fibrillation, 556 sinus rhythm), comprising 8-s contact force (CF) and bip

155 restored expression and cellular location to sinus rhythm control levels.

156 ere measured in right atrial samples from 76 sinus rhythm (control) and 72 chronic AF (cAF) patients.

157 nent atrial fibrillation than in age-matched sinus rhythm controls.

158 During the follow-up, the percentages of sinus rhythm decreased from 43% after 1 hour to 23% afte

159 py, 49 (46.7%) of those patients remained in sinus rhythm during follow-up.

160 Among 1817 patients with available sinus rhythm ECGs at baseline, there were 1281 (70%) wit

161 nderwent detailed endocardial and epicardial sinus rhythm electroanatomic mapping.

162 nsional electroanatomic maps acquired during sinus rhythm (endocardium, 509+/-291 points/map; epicard

163 All parents were asymptomatic and in sinus rhythm, except for 1 with undetected complete AV b

164 ricular tachycardia re-entry circuits during sinus rhythm focuses on sites with abnormal electrograms

165 Seven sham-operated animals were in sinus rhythm for 1 year.

166 tic resonance imaging volumetric data during sinus rhythm for all patients.

167 ffective antiarrhythmic drug for maintaining sinus rhythm for patients with atrial fibrillation.

168 VT and sinus rhythm fractionation sites were adjacent to LBs ap

169 Risk in Communities (ARIC) study who were in sinus rhythm, free of valvular disease, and had acceptab

170 n=675; mean age, 71+/-9 years; 60% women) in sinus rhythm from the population-based Northern Manhatta

171 r day 10, the percentage of G628S animals in sinus rhythm gradually declined until all animals were i

172 ly larger in paroxysmal AF compared with the sinus rhythm group (93.9 +/- 39.1 ml vs. 76.1 +/- 36.3 m

173 and posterior wall/septum ablation while in sinus rhythm (group 1), versus same ablation in group 1

174 A) or further ablation of subsequent ATs to sinus rhythm (group B).

175 Patients maintaining sinus rhythm had a lesser decline in DE between acute an

176 ow-up echocardiogram, patients in continuous sinus rhythm had greater reductions in left atrial size

177 in for patients with heart failure in normal sinus rhythm has not been definitively established.

178 tion in all-cause mortality in patients with sinus rhythm (hazard ratio 0.73, 0.67-0.80; p<0.001), bu

179 erval, 3.03-35.0) or AH(SVT)<AH(NSR) (normal sinus rhythm) His-refractory ventricular premature depol

180 d with better prognosis only for patients in sinus rhythm (HR: 1.16 per 10 beats/min increase, 95% CI

181 lectrical cardioversion immediately restored sinus rhythm in 102 sessions (71%).

182 ial activation mapping were performed during sinus rhythm in 22 patients before pulmonary vein isolat

183 Atropine restored sinus rhythm in 5 of 5 Ex rats with AF sustained >15 min

184 ariability have been measured at rest during sinus rhythm in 533 participants of the Muerte Subita en

185 /-32 beats per minute, P<0.001, and restored sinus rhythm in 7/7 dogs.

186 ents was immediately successful in restoring sinus rhythm in 71% of sessions.

187 It allowed restoration of sinus rhythm in a substantial proportion of patients und

188 Conventional mapping was performed in sinus rhythm in all, and a high-density Pentaray mapping

189 e and increasingly used approach to maintain sinus rhythm in atrial fibrillation patients, with promi

190 d second-line therapy for the maintenance of sinus rhythm in atrial fibrillation.

191 ity of I(Kur) as a target for maintenance of sinus rhythm in patients with a history of atrial fibril

192 ation (ie, cardioversion) and maintenance of sinus rhythm in patients with atrial fibrillation are re

193 r pharmacological therapy for maintenance of sinus rhythm in patients with both paroxysmal and persis

194 Restoring sinus rhythm in patients with heart failure (HF) and atr

195 sess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation [FORWARD]

196 Catheter ablation is effective in restoring sinus rhythm in selected patients with persistent AF and

197 In patients with heart failure in sinus rhythm, increasing TTR is associated with better o

198 During sinus rhythm intramural late potentials tended to be mor

199 Catheter ablation to restore and maintain sinus rhythm is a modality that promises to be advantage

200 Sinus rhythm is often needed to control symptoms; howeve

201 t in "atrial functional MR" that improves if sinus rhythm is restored.

202 oke can occur in patients with AF even after sinus rhythm is restored.

203 ion are another group in whom maintenance of sinus rhythm is thought to be advantageous.

204 prolonged QT diagnostic statement (assuming sinus rhythm <100 beats per minute and QRS duration <120

205 , a high baseline HSP27S level could predict sinus rhythm maintenance in the patients with PAF.

206 n, patients with AF termination had a higher sinus rhythm maintenance rate after a single procedure t

207 rall, 21+/-4 months after 1 PVI session, the sinus rhythm maintenance rate without antiarrhythmic dru

208 dergo PVI and leads to a substantial midterm sinus rhythm maintenance rate.

209 ial benefits of risk factor modification for sinus rhythm maintenance.

210 the presence of spectral AP alternans during sinus rhythm may obviate the need to actually demonstrat

211 rial fibrillation were older than those with sinus rhythm (mean age +/- standard deviation, 68 years

212 The sinus rhythm model showed a typical human atrial AP morp

213 greater all-cause mortality for patients in sinus rhythm (n = 14,166; adjusted HR: 1.11 per 10 beats

214 AT (n = 1), atrial fibrillation (n = 1), or sinus rhythm (n = 2) during the electrophysiological pro

215 atrial fibrillation (n = 158) and those with sinus rhythm (n = 416).

216 th Graves' hyperthyroidism with AF (n=17) or sinus rhythm (n=21) and 10 healthy control subjects was

217 an atrial myocytes obtained from patients in sinus rhythm, nNOS inhibition was sufficient to recapitu

218 giograms obtained in 65 patients with normal sinus rhythm (normal group) and seven with atrial fibril

219 At 5 years, 73% were in sinus rhythm off antiarrhythmic medications after single

220 Those with sinus rhythm on 12-lead ECG, no history of AF, and >/=2

221 ibrillation the first day were reported with sinus rhythm on day 2.

222 1% underwent cardioversion, and 92% were in sinus rhythm on discharge.

223 icular hypertrophy with no history of AF, in sinus rhythm on their baseline electrocardiogram, random

224 Of the 54 patients in sinus rhythm, only 18 (33%) converted to sinus rhythm af

225 either had a propagation sequence similar to sinus rhythm or arose near papillary muscles, and (2) st

226 ure with reduced ejection fraction in either sinus rhythm or atrial fibrillation (AF).

227 The presence of sinus rhythm or atrial fibrillation was ascertained from

228 and excellent image quality in patients with sinus rhythm or atrial fibrillation.

229 FIRM ablation terminated AF to sinus rhythm or atrial flutter or tachycardia in 59% (PA

230 r sequential movement of ripple bars, during sinus rhythm or pacing, which were distinct from surroun

231 ith rheumatic mitral valve disease in either sinus rhythm or persistent AF were analyzed using a comb

232 lectrograms were collected using CARTO3v4 in sinus rhythm or ventricular pacing and reviewed for ripp

233 normal ventricular activities (LAVAs) during sinus rhythm or ventricular pacing would be a useful and

234 (86.1%), AF acutely terminated (n=20; 16 to sinus rhythm) or organized (n=11; 19+/-8% slowing) with

235 ted to display ventricular activation during sinus rhythm over 8 isochrones.

236 35.7% higher, respectively, than patients in sinus rhythm (p < 0.05).

237 atria of chronic AF patients (by 54% versus sinus rhythm; p<0.05).

238 ial JPH2 levels per RyR2 channel compared to sinus rhythm patients and an increased frequency of spon

239 Right-atrial appendages from control sinus rhythm patients or patients with pAF (last episode

240 IINP levels were highest in AF versus normal sinus rhythm (PICP: 451.7 +/- 200 ng/ml vs. 293.3 +/- 11

241 R+S)(VT) divided by the percentage R-wave in sinus rhythm (R/R+S)(SR).

242 Mortality was lower for patients in sinus rhythm randomized to beta-blockers (HR: 0.73 vs. p

243 Stable sinus rhythm restoration was immediate in 61.5% of patie

244 Six horses were evaluated during sinus rhythm, right ventricular pacing without preceding

245 ents with atrial fibrillation and those with sinus rhythm showed no difference in heart rate (P = .16

246 months, 88% of ablation patients maintained sinus rhythm (single-procedure success 68%).

247 el omnipolar peak-to-peak voltages (Vmax) in sinus rhythm (SR) and AF.

248 D distributions in the intact ventricles for sinus rhythm (SR) and epicardial pacing (EP) by using a

249 A total of 1262 patients manifested sinus rhythm (SR) at baseline/SR at discharge, 113 SR ba

250 al EP imaging modality, was performed during sinus rhythm (SR) in 24 subjects with infarct-related my

251 pacity among patients with HFpEF who were in sinus rhythm (SR) or AF.

252 bclinical cardiomyopathy that persists after sinus rhythm (SR) restoration, providing a substrate for

253 mias in atrial trabeculae from patients with sinus rhythm (SR), but whether these arrhythmias occur i

254 ony, which also occurs to some degree during sinus rhythm (SR).

255 compromised compared to patients with PH and sinus rhythm (SR).

256 results with those obtained in patients with sinus rhythm (SR).

257 tion potential normalises after 2-4 weeks of sinus rhythm, suggesting that antiarrhythmic drugs might

258 D40L levels were measured in 144 patients in sinus rhythm the day before off-pump coronary artery sur

259 During normal sinus rhythm, the canine SAN is functionally insulated f

260 Among patients with reduced LVEF who were in sinus rhythm, there was no significant overall differenc

261 nduced activation from 228.4+/-7.6 ms during sinus rhythm to 328.3+/-6.2 ms during cardiac memory.

262 roanatomical voltage map was obtained during sinus rhythm to define scar areas (<1.5 mV) and CCs insi

263 ular rate control and require restoration of sinus rhythm to improve their quality of life.

264 ecordial transition occurring later than the sinus rhythm transition excluded an LVOT origin with 100

265 inical outcomes in heart failure patients in sinus rhythm treated with warfarin.

266 followed for 1 year to assess maintenance of sinus rhythm using an implantable loop recorder.

267 Absolute timing difference for sinus rhythm was 10+/-5 and 11+/-8 ms respectively, and

268 e compared, and the effect of restoration of sinus rhythm was assessed by follow-up echocardiograms.

269 A higher proportion of time spent in sinus rhythm was associated with a greater improvement i

270 owever, a higher proportion of time spent in sinus rhythm was associated with a modestly greater impr

271 By contrast, sinus rhythm was associated with beneficial effects on N

272 titive electrical cardioversion in restoring sinus rhythm was disappointing.

273 After the first ablation procedure, sinus rhythm was documented in 41 of 202 (20.3%) patient

274 Stable sinus rhythm was maintained in 32 patients (64%) of the

275 After multiple procedures, sinus rhythm was maintained in 91 of 202 (45.0%) patient

276 82%, p = 0.005) compared with those in whom sinus rhythm was not restored.

277 Acute conversion to sinus rhythm was observed in 2 patients after ablation o

278 lectrodes, interelectrode distance: 2 mm) of sinus rhythm was performed in 185 patients during corona

279 Further maintenance of sinus rhythm was required in the rhythm-control group, a

280 d consistent RA-left atrium activation until sinus rhythm was restored.

281 culated activation for the in situ hearts in sinus rhythm was similar to patterns recorded in Langend

282 bnormal ventricular activities (LAVA) during sinus rhythm were assessed with regard to the WT.

283 Pre-operative and intraoperative sinus rhythm were associated with improved survival.

284 aced rhythms, and bundle branch block during sinus rhythm were excluded.

285 Atrial ectopics during sinus rhythm were observed more frequently when CF was >

286 During the follow-up, 94 patients maintained sinus rhythm, whereas 50 experienced AF recurrence.

287 r day) is a better treatment for patients in sinus rhythm who have a reduced left ventricular ejectio

288 We randomly assigned 1922 patients in sinus rhythm who were scheduled for elective cardiac sur

289 thirty consecutive patients of either sex in sinus rhythm, who were admitted to the medical emergency

290 The restoration of sinus rhythm with CA results in significant improvements

291 Maintenance of sinus rhythm with drugs or catheter ablation should be c

292 2 patients (age 63 +/- 15 years, 60% men) in sinus rhythm with organic MR (regurgitant volume 68 +/-

293 s a substantial evidence base in patients in sinus rhythm with significant systolic dysfunction, symp

294 ysis Program (GE Healthcare), and exhibiting sinus rhythms with heart rate <100 beats per minute and

295 with atrial fibrillation than in those with sinus rhythm, with a mean difference of 4.03 mSv (95% CI

296 Conversion from AF to sinus rhythm within the first 90 min (primary end point)

297 roup B and 30 of 50 (60%) in Group C were in sinus rhythm without antiarrhythmic drugs (p = 0.40).

298 roup B and 17 of 50 (34%) in Group C were in sinus rhythm without antiarrhythmic drugs (p = 0.84).

299 dure, 97 of 150 (64.7%) patients remained in sinus rhythm without antiarrhythmic drugs.

300 Whether prompt restoration of sinus rhythm would improve outcomes in patients hospital